Anthem Biosciences IPO Subscription History

As of July 21, 2025, the Anthem Biosciences IPO has been subscribed 63.86 times overall. The IPO is fully subscribed with strong investor demand indicating extremely high interest.

The Anthem Biosciences IPO subscription window was open from July 14, 2025 to July 16, 2025. Investors could apply through their demat account or ASBA facility.

The Anthem Biosciences IPO has a price band of ₹540 to ₹570 per share, with a lot size of 26 shares. Minimum retail investment: ₹14,040 (lower band) or ₹14,820 (upper band).

The QIB category has been subscribed 182.65 times. QIBs were offered 12,543,518 shares. Strong QIB subscription indicates high institutional confidence.

Retail investors subscribed 5.64 times. Retail was offered 21,951,158 shares.

Overall NII: 42.36×. bNII (>₹10L): 48.94×, sNII (<₹10L): 29.19×. NII includes HNIs and corporate entities investing above ₹2 lakh.

Basis of allotment is on July 17, 2025. Check via the registrar's website, KFin Technologies Limited using your PAN number, application number, or DP/Client ID. You can also check on BSE/NSE websites or through your broker's app.

Anthem Biosciences IPO is expected to list on July 21, 2025. Shares will list on NSE,BSE. Allotted shares are credited to your demat account 1 business day before listing.

A subscription multiple of 63.86× means investors have bid for 63.86 times the total shares available. Since the IPO is oversubscribed, not every applicant will receive shares, allotment happens via lottery (for retail) or proportionately (for other categories). Higher multiples generally reduce allotment probability.

Based on the current retail subscription of 5.64×, the estimated allotment probability for retail investors is Moderate. Better odds than heavily subscribed IPOs. Retail allotment in oversubscribed IPOs is done by computerised lottery, each valid application has an equal probability regardless of the number of lots applied for.

You can apply for Anthem Biosciences IPO through: (1) ASBA (Application Supported by Blocked Amount) via your bank's net banking or mobile app, (2) UPI-based application through your broker's app (Zerodha, Groww, Angel One, etc.), or (3) directly via your demat account. The amount is blocked in your account and deducted only upon allotment. Applications were accepted from Jul 14 to Jul 16, 2025.

The grey market premium (GMP) reflects unofficial pre-listing trading sentiment. For the latest Anthem Biosciences IPO GMP data, check the IPORise GMP page. Note: GMP is unofficial, speculative, and not a guaranteed indicator of listing price. Use it only as a sentiment signal alongside official subscription data.